Long-term response in patient with recurrent oropharyngeal carcinoma treated with cetuximab, docetaxel and cisplatin (TPEx) as first-line treatment followed by cetuximab maintenance

J. Guigay, C. Even, L. Mayache-Badis, M. Debbah, E. Saada-Bouzid, Y. Tao, F. Deschamps, F. Janot, N. Lezghed, C. Michel
  • Oral Oncology, May 2017, Elsevier
  • DOI: 10.1016/j.oraloncology.2017.03.009

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.oraloncology.2017.03.009

The following have contributed to this page: Cécile MICHEL